Business Context and Reporting Period
This Form 8-K is a current report filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on August 28, 2019. The registrant is incorporated in Delaware and its common stock trades on the NYSE American under the symbol MRIC. The filing serves as a Regulation FD disclosure regarding an updated investor presentation posted to the company's website.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the availability of an investor presentation (Exhibit 99.1) and does not contain audited or unaudited financial statements.
Material Changes
No material financial changes versus a prior comparable period are reported in this text. The only reported event is the dissemination of an updated investor presentation to analysts and investors.
Guidance, Outlook, and Risks
The filing explicitly states that the information contained in the investor presentation (Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be incorporated by reference into other filings unless expressly stated. Consequently, specific guidance, outlook, management commentary, risks, or contingencies are not detailed within the body of this 8-K.
Key Facts for Investor Verification
- Verify the company name is MRI Interventions, Inc. (MRIC), as the request metadata incorrectly listed Clearpoint Neuro, Inc.
- Review Exhibit 99.1 (Investor Presentation dated August 2019) for actual financial data, guidance, and strategic updates, as this 8-K only references the document.
- Note that the presentation is not legally "filed" with the SEC and carries different liability standards than formal financial reports.
- Confirm the trading symbol MRIC on the NYSE American exchange.